Skip to main content

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Projects

European Stroke Research Network (EUSTROKE) Grant Agreement Nº 202213

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Maria Mar Hernandez Guillamon, Carlos Molina Cateriano, Anna Rosell Novel
Funding agency: EUROPEAN COMMISSION
Funding: 463200
Reference: EUSTROKE_FP7HEALTH2007
Duration: 01/03/2008 - 31/08/2013

RENEVAS - Red de Investigación Cooperativa Neurovascular

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 793573.69
Reference: RD06/0026/0010
Duration: 02/01/2007 - 31/12/2013

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50600
Reference: 2005SGR 00614
Duration: 01/01/2006 - 31/12/2008

Impacto de las concentraciones de proteina C reactiva, metaloproteasas de la matriz y plasminogen activador inhibitor-1 (PAI-1) y de determinados polimorfismos de sus genes sobre progresión y complicación de la aterosclerosis intracraneal sintomática.

IP: Carlos Molina Cateriano
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 41400
Reference: PI040438
Duration: 01/01/2005 - 28/12/2007

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Borja González Rodríguez

Borja González Rodríguez

Reconstructive Surgery of the Locomotor System
Read more
Joana Rita Marques Soares

Joana Rita Marques Soares

Predoctoral researcher
Systemic Diseases
Read more
Maria Pilar Redondo Gonzalez

Maria Pilar Redondo Gonzalez

Research assistant
Microbiology
Read more
Silvia Muñoz Caller

Silvia Muñoz Caller

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.